Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Earnings for Mankind Pharma Limited (MANKIND.NS)
Earnings in 2023 (TTM): $283.95 M
According to Mankind Pharma Limited's latest financial reports the company's current earnings (TTM) are $283.95 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Mankind Pharma Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $283.95 M | $226.38 M |
| 2022 | $196.31 M | $151.7 M |
| 2021 | $233.69 M | $169.65 M |
| 2020 | $200.2 M | $149.76 M |
| 2019 | $170.15 M | $121.95 M |
| 2018 | $103.51 M | $68.47 M |